CareDx Inc (CDNA) - Long-Term Liabilities to Capital

CareDx, Inc. - graphic logo of issuer CDNA

CareDx, Inc (CDNA) specializes in transplant diagnostics, optimizing costs through a single laboratory center for the entire country. Efficiency is enhanced by implementing robots for high-precision DNA sequencing, which eliminates manual labor. However, changes in Medicare reimbursement rules create risks for margins, despite legal protections. The current indicator stands at 0.03, which clearly demonstrates the market trend visualized in monetary format.

CareDx, Inc - CDNA Long-Term Debt to Capital (period 07/04/2022 - 10/30/2026)

Comprehensive metric breakdowns and analytics for CareDx Inc (CDNA)

- stock value and consensus price forecast:
Stock Quotes CareDx|CDNA - Analyst Consensus Forecast
- market capitalization indicators:
Market Value CareDx, Inc.|CDNA - Enterprise Value
- book value of equity indicators:
Equity per Share CareDx|CDNA - Book Capitalization|Market Capitalization to Book Value Ratio caredx.com|CDNA - Aggregate Company Assets
- debt and solvency information:
Debt to Equity Ratio CareDx, Inc|CDNA - Long-Term Debt to Capital|Short-Term Debt to Capital CareDx Corp|CDNA - Company Debts|Debt to Book Capitalization Ratio CareDx, Inc.|CDNA - Company Long-Term Liabilities|Short-Term Debt CareDx|Interim Coverage Ratio caredx.com
- financial results and valuation multiples details:
CDNA - Net Profit
Comprehensive company analysis:CareDx, Inc
Product sample of CareDx Inc

Recurring revenues for CareDx, Inc (CDNA) from lifelong transplant monitoring ensure high cash flow stability, minimizing risks associated with debt servicing. By analyzing the long-term financial leverage ratio, an investor can see the ratio of liabilities with a maturity of over one year to equity, which allows for an assessment of the business's dependence on external borrowing and its overall stress resilience.

Competing companies

Long-Term Debt to Equity Ratio Agilent Technologies, Inc. (A)|Long-Term Debt to Capital DGX|ILMN - Long-Term Liabilities to Capital|Long-Term Debt to Capital EXAS (Exact Sciences)|RVTY: Long-Term Debt to Capital Ratio|Bio-Rad - Long-Term Debt to Capital|NNNN - Long-Term Debt to Capital|Sterigenics (SHC) - Long-Term Debt to Equity|Long-Term Debt to Capital Ratio QDEL|OPK (OPKO Health, Inc.) - Long-Term Debt to Capital|Long-Term Debt to Capital maravai.com|Long-Term Debt to Equity Fulgent Genetics (FLGT)|Long-Term Debt to Equity LAB (Standard BioTools Inc)|Cytek Bio - Long-Term Debt to Equity Ratio|OraSure Corp (OSUR) - Long-Term Liabilities to Capital|XGN - Long-Term Debt to Equity|Ratio of Long-Term Indebtedness to Capital mdxhealth.com MDXH|LUCD: Long-Term Debt to Capital|PRE - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Insight Molecular Diagnostics, Inc.|Trinity Biotech Corp (TRIB) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Capital PRPH|Long-Term Debt to Equity Ratio ainos.com AIMD|Long-Term Debt to Capital CODX (Co-Diagnostics)|Long-Term Debt to Capital Heart Test Laboratories, Inc. HSCS|BMRA - Long-Term Debt to Equity|Long-Term Debt to Capital Coefficient CDIO (Cardio Diagnostics)|VRAX: Long-Term Debt to Capital|Long-Term Liabilities to Capital bluejaydx.com (BJDX)|AWH (Aspira Women's Health Inc.) - Long-Term Debt to Capital|Long-Term Debt to Capital Ratio AXDX (Accelerate Diagnostics Inc.)|Long-Term Debt to Equity Ratio CNTG (CENTOGENE, N.V.)|enzo.com - Long-Term Debt to Capital Ratio|Fresh2 Group - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Coefficient GENE|23andMe - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital Psychemedics Corp. PMD